Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Banting Postdoctoral Fellowship Program

Direct Payment

$140,000.00

Development and characterization of new antivirals against ebolavirus

EF 2011-12

Résumé
Ebolavirus is an enveloped RNA virus that causes severe hemorrhagic fever with a lethality rate that can reach up to 90%. The increasing number of ebolavirus outbreaks in endemic regions of Africa and its potential use as a biological warfare agent are alarming. Importantly, there is no available vaccine or effective therapy against this virus, and this is partly due to the poor understanding of the underlying mechanisms of Ebola entry into host cells. We propose to investigate Ebola entry using state-of-the-art technology to screen for cellular factors that play critical roles during infection. The discovery of cellular proteins involved in Ebola entry will help to better understand how the virus initiates infection. Our study will ultimately lead to the development of new antiviral drugs that can help in blocking viral entry and spread, which can have a great impact in the fight against this deadly virus.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
247498
Name
Côté Marceline
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Development and characterization of new antivirals against ebolavirus
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Antivirals; Click Chemistry; Ebola Virus; Hemorrhagic Fever Viruses; Mass Spectrometry; Small Molecule Inhibitors; Viral Entry
Abstract
Ebolavirus is an enveloped RNA virus that causes severe hemorrhagic fever with a lethality rate that can reach up to 90%. The increasing number of ebolavirus outbreaks in endemic regions of Africa and its potential use as a biological warfare agent are alarming. Importantly, there is no available vaccine or effective therapy against this virus, and this is partly due to the poor understanding of the underlying mechanisms of Ebola entry into host cells. We propose to investigate Ebola entry using state-of-the-art technology to screen for cellular factors that play critical roles during infection. The discovery of cellular proteins involved in Ebola entry will help to better understand how the virus initiates infection. Our study will ultimately lead to the development of new antiviral drugs that can help in blocking viral entry and spread, which can have a great impact in the fight against this deadly virus.
Competitiondate
201111
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Côté, Marceline
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~